CAS: 1242592-26-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Doxorubicinol HCl (Mixture of Diasteromers) REF: 4Z-D-343CAS: | - - - | To inquire | Tue 21 May 24 |
| Doxorubicinol-13C-d3 HCl (Mixture of Diasteromers) REF: 4Z-D-344CAS: 1242592-26-2 | - - - | To inquire | Tue 28 May 24 |
 | Doxorubicinol Citrate REF: 3D-FD71620CAS: 1242592-26-2 | Min. 95% | To inquire | Tue 02 Jul 24 |
Ref: 4Z-D-343
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
Doxorubicinol-13C-d3 HCl (Mixture of Diasteromers)
CAS:1242592-26-2
Formula:
CC26H28NO11D3
Molecular weight:
549.58 36.46
Ref: 4Z-D-344
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 May 2024
Doxorubicinol Citrate
CAS:1242592-26-2
Doxorubicinol citrate is a doxorubicin prodrug that is used in the treatment of acute myeloid …
Formula:
C87H101N3O40
Purity:
Min. 95%
Molecular weight:
1,828.73 g/mol
Ref: 3D-FD71620
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
